Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jun;19(6):627-32.
doi: 10.1007/s00467-004-1438-8. Epub 2004 Apr 3.

Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome

Affiliations
Comparative Study

Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome

Wai Cheung et al. Pediatr Nephrol. 2004 Jun.

Abstract

Earlier studies have demonstrated a strong association of steroid-responsive nephrotic syndrome (SRNS), atopy, and elevated serum IgE levels. Interleukin (IL-13) gene expression is significantly increased in children with SRNS in relapse. As interferon (IFN)-gamma, IL-13, and IL-4 have regulatory effects on IgE synthesis, we examined the relationship between intracellular cytokine production and serum IgE levels in children with SRNS, in order to further define the reported association with atopy. The median serum IgE levels in nephrotic patients in relapse with (492 U/ml) or without atopy (561 U/ml) were significantly higher than those in remission (221 U/ml, P<0.002 or 90 U/ml, P<0.001, respectively) and non-atopic controls (177 U/ml) (P<0.001). The percentage of CD3+ IL-13-producing cells was significantly higher in nephrotic children in relapse, and correlated with the serum IgE levels during the active phase of the disease (r=0.90, P<0.001). These data suggest that the elevated serum IgE levels during relapses of SRNS were the result of upregulation of IL-13. This probably reflects some common immune activation following various stimuli, rather than a direct association with atopy.

PubMed Disclaimer

References

    1. J Clin Lab Immunol. 1986 Feb;19(2):91-7 - PubMed
    1. J Pediatr. 1981 Apr;98(4):561-4 - PubMed
    1. J Trop Pediatr. 1997 Apr;43(2):93-7 - PubMed
    1. Clin Sci (Lond). 2002 May;102(5):507-12 - PubMed
    1. Lancet. 1974 Sep 7;2(7880):556-60 - PubMed

Publication types

LinkOut - more resources